Tag: Anticoagulants
Clopidogrel + Aspirin Cuts Ischemic Events in Stroke, TIA
However, combination is associated with increased risk of major hemorrhage within 90 days
Anticoagulants in Seniors With A-Fib, CKD Ups Stroke, ICH Risk
Anticoagulants linked to increased risk of ischemic stroke and hemorrhage, but lower all-cause mortality
Anticoagulation Guidance Issued for Cardiopulmonary Bypass
Recommendations for heparin dosing and monitoring, contraindications and alternatives, reversal
Ocular Safety Profile of Novel Oral Antithrombotics Explored
Prasugrel has no increased ocular risk versus clopidogrel; dabigatran, rivaroxaban may reduce risk
Pharmacomechanical Thrombolysis No Benefit in DVT
Addition of pharmacomechanical catheter-directed thrombolysis resulted in higher risk of bleeding
Storage in Dose Administration Aids Doesn’t Affect Warfarin
Repackaging of warfarin sodium tablets into dose administration aids doesn't affect chemical stability
ACC Guides Treatment of Bleeding With Oral Anticoagulation
Pathway supports clinician decision making during management of patients with bleeding complications
NOACs Show Lower Risk of Adverse Renal Outcomes in A-Fib
Compared with warfarin, dabigatran and rivaroxaban linked to lower risk of adverse renal outcomes
Genotype-Guided Warfarin Dosing Cuts Adverse Events
Risk of composite of major bleeding, INR ≥4, VTE, death down for hip, knee arthroplasty patients
CYP2C9 Variants Linked to Clinical Events in VTE
Risk of any clinical event, death, non-major bleeding up for seniors treated with vitamin K antagonists
